NCT03175302 PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
| NCT ID | NCT03175302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Cognitive Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 25,240 participants |
| Start Date | 2018-06-28 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25,240 participants in total. It began in 2018-06-28 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study leverages a modernized digital version of a well-known cognitive screening tool to examine pre and post operative cognitive function after surgery in adults age 65 years or more. Machine learning algorithms will be applied to the hospital wide standard of care cognitive metric to identify risk for post-operative cognitive complications.
Eligibility Criteria
Inclusion Criteria: * \>/= 65 years of age * screening within the University of Florida (UF) Health Preoperative clinic * presurgical cognitive screening with the digital Clock Drawing Tool (dCDT) Exclusion Criteria: * \< 65 years of age * did not complete screening within the UF Health Preoperative clinic * did not complete the presurgical cognitive screening with the digital Clock Drawing Tool (dCDT)
Contact & Investigator
Catherine Price, Ph.D.
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT03175302 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cognitive Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03175302 currently recruiting?
Yes, NCT03175302 is actively recruiting participants. Contact the research team at cep23@phhp.ufl.edu for enrollment information.
Where is the NCT03175302 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT03175302 clinical trial?
NCT03175302 is sponsored by University of Florida. The principal investigator is Catherine Price, Ph.D. at University of Florida. The trial plans to enroll 25,240 participants.